JPMorgan Sees 140% Upside In This eVTOL Stock — And It's Not Joby Or Archer

JPMorgan sets a $6 target on Eve Holding (EVEX) vs. the current ~ $2.50 share price, implying roughly 140% upside. The analyst highlights operational de-risking — >28 flight tests and >1 hour of logged flight time, plans for hundreds of flights and multiple prototypes toward entry into service — plus over $540M of liquidity (runway to ~2027–2028) and a ~2,700-aircraft non-binding pipeline (~$13.5B potential). JPMorgan argues the stock is trading at its lowest level relative to net liquidity since listing, suggesting downside may be limited and the note could prompt a re-rating of the name.

Analysis

Eve’s current market treatment looks like a liquidity/optionality discount rather than a pure execution doubt — that creates a classic asymmetric payoff where balance-sheet visibility compresses left-tail risk while optionality on certification and early orders sits on the right tail. The structural second-order winner is not only the OEM but suppliers of modular electric propulsion and high-volume composites that can service multiple platforms; these suppliers will see leverage to volume ramp assumptions long before cabin or air-traffic services monetization materializes.

Key near-term catalysts are binary certification and conversion cadence from non-binding to firm orders; both operate on multi-quarter to multi-year timelines and will be the primary drivers of realized revenue vs. theoretical pipeline. Counterparty and supply-chain concentration (single-source battery cells, flight-control avionics) are the most credible operational failure modes — a single supplier delay can cascade certification slip and re-cost schedules for the entire cohort.

The consensus misses that survivorship in eVTOL will be driven as much by funding runway and service-ops economics as by prototype milestones. If runway conserves capital and the firm nails a phased regional entry with outsourced O&M, valuation re-rating can occur materially before widespread fleet deployment; conversely, incremental cap raises at distressed prices would reintroduce dilution risk and reset optionality. Monitor volumetric cost per flight-hour and post-certification unit economics — those will convert narrative value into recurring revenue multiples.

Key Decisions for Investors

• Long EVEX equity (size 1–1.5% NAV) — accumulate on soft intraday moves and hold through the next 12–18 months; target asymmetric payoff: preserve downside with a 30–40% cash stop, pursue 2x+ upside if certification milestones and order conversions track. (Ticker: EVEX)
• Long-dated call spread to cap premium outlay — buy Jan-2027 EVEX 5/10 call spread (1:1) sized at 0.5% NAV to capture upside re-rating with defined max loss; R/R ~3:1 if conversion narrative re-accelerates. (Ticker: EVEX)
• Catalyst option play (shorter-term) — buy a small position in 3–6 month calls ahead of major certification/flight-test updates (allocate <0.25% NAV) to capture volatility spikes; exit within 3 trading days of the release or on 50% realized gain. (Ticker: EVEX)
• Hedge: buy aviation-supply downside or use put protection — allocate a 0.5% NAV to puts or inverse exposure on concentrated suppliers if certification slips; this protects equity exposure from cascade effects tied to a supplier failure or unexpected funding raise. (Use bespoke hedges per desk liquidity; underlying correlated to EVEX)